Detecting Malnutrition in Cancer and Elderly Patients
Early Detection of Malnutrition in Oncology Patients and People Over 65 Years of Age
This study is testing a new way to spot malnutrition in cancer patients and older adults in the hospital to see if it can help improve their health and quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Institute of Health Information and Statistics of the Czech Republic Government |
| Locations | 9 sites (Brno and 8 other locations) |
| Trial ID | NCT06499623 on ClinicalTrials.gov |
What this trial studies
This project is a national, prospective, multicenter pilot initiative aimed at early detection of malnutrition among oncology patients and hospitalized individuals aged 65 and older in the Czech Republic. The study will implement a standardized procedure for screening malnutrition using methods such as blood tests, bioelectrical impedance analysis, and nutritional risk assessment questionnaires. Approximately 2,000 patients will be evaluated to assess the effectiveness of this approach, which is expected to improve the quality of life and treatment outcomes for these vulnerable populations.
Who should consider this trial
Good fit: Ideal candidates include oncology patients aged 18 and older with a survival prognosis of at least 3 months, and hospitalized patients aged 65 and older who have been admitted for at least 14 days.
Not a fit: Patients who do not agree to participate in the project will not benefit from this study.
Why it matters
Potential benefit: If successful, this project could lead to earlier identification and intervention for malnutrition, significantly enhancing the quality of life and treatment efficacy for affected patients.
How similar studies have performed: Other studies have shown success in similar approaches to malnutrition screening, indicating a promising avenue for improving patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Cohort Oncological patients: * 18+ * an oncological diagnosis * a survival prognosis of at least 3 months Cohort Patients older than 65 years: * 65+ * hospitalization at least 14 days or longer Exclusion Criteria (both cohorts): * not agreeing to participate in the project
Where this trial is running
Brno and 8 other locations
- Brno University Hospital — Brno, Czechia (Enrolling_by_invitation)
- Masaryk Memorial Cancer Institute — Brno, Czechia (Recruiting)
- Hospital AGEL Nový Jičín a.s. — Nový Jičín, Czechia (Recruiting)
- University Hospital Olomouc — Olomouc, Czechia (Enrolling_by_invitation)
- University Hospital Pilsen — Pilsen, Czechia (Enrolling_by_invitation)
- Bulovka Hospital — Prague, Czechia (Recruiting)
- General University Hospital, Prague — Prague, Czechia (Enrolling_by_invitation)
- Military University Hospital, Prague — Prague, Czechia (Recruiting)
- University Hospital, Motol — Prague, Czechia (Recruiting)
Study contacts
- Study coordinator: Nikola Stourac
- Email: nikola.stourac@uzis.cz
- Phone: +420 739 012 354
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.